Thank you, Mr. Chair.
We concur with the honourable member's concern, and it's one of the concerns that Mr. Glover raised in his opening statement. Without adequate long-term testing of the safety and effectiveness of the substitutes for use in the same environment in which DEHP-containing devices are currently used, we are not certain of the potential risks that the substitution could incur.
That being said, we are committed to moving to phasing out their use through substitution, but we are concerned about the approach taken in the bill.